| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |